Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Articles

FDA Caught in Political Crossfire

Officials struggle to maintain the credibility of its drug regulatory process after accusations of intentionally delaying COVID-19 vaccine testing for political reasons.

Drug Pricing Back in the Spotlight

Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?

Pandemic Fears Stoke Calls for New Vaccines and Global Health Initiatives

Pharmaceutical Executive

Public health authorities and the biomedical research community are seeking new strategies to address global health threats, writes Jill Wechsler.

FDA Moves Forward on Mutual GMP Inspections with Europe

The agency hopes to better use global resources and avoid duplicate inspections of foreign facilities.